The present invention encompasses multiunit particulate sustained release dosage form of carbamazepine, or its pharmaceutically acceptable salts, solvates, hydrates, etc. The carbamazepine minitablets contains a single uniform population of minitablets for the treatment of grand mal and psychomotor or focal seizures. The proposed invention also provides method for producing the said formulation.